Persistent URL of this record https://hdl.handle.net/1887/95161
In Collections
This item can be found in the following collections:
![Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
- All authors
- Sonnenblick, A.; Agbor-Tarh, D.; Bradbury, I.; Cosimo, S. di; Azim, H.A.; Fumagalli, D.; Sarp, S.; Wolff, A.C.; Andersson, M.; Kroep, J.; Cufer, T.; Simon, S.D.; Salman, P.; Toi, M.; Harris, L.; Gralow, J.; Keane, M.; Moreno-Aspitia, A.; Piccart-Gebhart, M.; Azambuja, E. de
- Date
- 2017-05-01
- Journal
- Journal of Clinical Oncology
- Volume
- 35
- Issue
- 13
- Pages
- 1421 - +